About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Advanced Therapy Medicinal Products (ATMP) Market Size by 2032
Advanced Therapy Medicinal Products (ATMP) Market

Advanced Therapy Medicinal Products (ATMP) Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy, CAR-T Therapy, Tissue Engineered Products), By Manufacturer (Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI54723DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Advanced Therapy Medicinal Products (ATMP) Market Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Others
        1. By Value
    4. U.S.
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Others
        1. By Value
    4. U.K.
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Others
        1. By Value
    4. China
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Others
        1. By Value
    4. UAE
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Others
        1. By Value
    4. Brazil
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Advanced Therapy Medicinal Products (ATMP) Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Spark Therapeutics, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Organogenesis Inc.
    3. Bluebird Bio, Inc.
    4. Novartis AG
    5. Bristol-Myers Squibb
    6. Gilead Lifesciences, Inc.
    7. Kolon TissueGene, Inc.
    8. MEDIPOST
    9. JCR Pharmaceuticals Co., Ltd.
    10. Vericel Corporation
    11. UniQure N.V.
    12. Celgene Corporation
    13. Corning Incorporated
    14. Cytiva
    15. Astellas Pharma Inc.
    16. PHARMICELL Co., Ltd
    17. Orchard Therapeutics
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.